Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...
AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Tezspire has shown promising results in the Phase III WAYPOINT trial, ...
In 2021, the family pledged £50million to Oxford university for a new Poonawalla Vaccines Research Building, having manufactured hundreds of millions of doses of the Oxford/AstraZeneca vaccine.